GSA Capital Partners »

Tvardi Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $34k 18k 1.90

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Shor Corp Etf (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Agree Realty Corporation (ADC)
Bank Ozk (OZK)
PNM Resources (TXNM)
Essential Properties Realty reit (EPRT)
TJX Companies (TJX)
Everest Re Group (EG)
O'reilly Automotive (ORLY)
American Airls (AAL)
Medtronic SHS (MDT)
Northrop Grumman Corporation (NOC)

View all positions for GSA Capital Partners

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Capital Management
American Financial Group
UBS Group
Silvercrest Asset Management Group
State Street Corporation
BlackRock
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Duncan Williams Asset Management
Vanguard Fiduciary Trust
Russell Investments
Susquehanna International
AQR Capital Management

View all funds holding Tvardi Therapeutics